Key takeaways for Louisiana
- • No GLP-1 is FDA-approved for pre/post-bariatric use specifically.
- • Pre-op: liver shrinkage and risk optimization; post-op: regain management.
- • Observational data show 8-15% additional weight loss post-op on GLP-1.
- • Louisiana Medicaid (Healthy Louisiana) coverage rules apply for Bariatric Pre- and Post-Op Support patients in Louisiana — see Medicaid section below.
- • 13 GLP-1 telehealth providers available nationwide.
Why GLP-1 medications for Bariatric Pre- and Post-Op Support
No GLP-1 is FDA-approved specifically for bariatric pre/post-op support. Off-label preoperative use can reduce liver volume and improve surgical access; off-label postoperative use addresses the roughly 25-30% of bariatric patients who experience clinically significant weight regain. Evidence grade: C (observational data growing; few RCTs). The ASMBS 2022 statement and emerging 2024-2025 consensus recognize this as an evolving practice. Pancreatitis and gastroparesis risks may merit extra caution in altered post-op anatomy.
Louisiana-specific context
Louisiana has telehealth access concentrated in New Orleans, Baton Rouge, Shreveport metros, with additional reach to Lafayette and Lake Charles. Ochsner Health, LCMC Health is the largest in-state academic medical center for endocrine + obesity-medicine specialty consults. The state health authority publishes prescribing + coverage updates at ldh.la.gov.
Louisianatelehealth & pricing rules
- • Louisiana permits audio-only and asynchronous telehealth visits for GLP-1 care.
- • Louisiana allows new-patient telehealth prescribing without a prior in-person visit.
- • Typical cash GLP-1 price in Louisiana: ~$218/mo (compounded options often lower, brand higher).